THOUSAND OAKS, Calif., Dec. 10, 2013 /PRNewswire/ — Amgen (NASDAQ:AMGN) and its subsidiary Onyx Pharmaceuticals, Inc. today announced that they will hold a post American Society of Hematology (ASH) summary webcast on Wednesday, Dec. 11, 2013, at 11 a.m. PST. Pablo Cagnoni, M.D., president of Onyx Pharmaceuticals, Inc. and Anthony C. Hooper, executive vice president of Global Commercial Operations at Amgen, will participate in the call to discuss a brief summary of data presented … [visit site to read more]
- Amgen Inc. (NASDAQ:AMGN) – Amgen to Highlight New Evolocumab (AMG 145) Data at Upcoming American Heart Association Scientific Sessions 2013
- Stock Update: Amgen Inc. (NASDAQ:AMGN) – Amgen Foundation Commits $2.5 Million In New Grants To Engage 50,000 Students Each Year In The Thrill Of Scientific Inquiry
- Greek downgrade weakens Euro, China & Australia post strong trade surplus